Concurrent Investment Advisors LLC Sells 797 Shares of The Clorox Company (NYSE:CLX)

Concurrent Investment Advisors LLC decreased its stake in shares of The Clorox Company (NYSE:CLX) by 5.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,287 shares of the company’s stock after selling 797 shares during the period. Concurrent Investment Advisors LLC’s holdings in Clorox were worth $2,483,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CLX. Brooklyn Investment Group lifted its position in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares during the period. Prospera Private Wealth LLC bought a new position in Clorox in the third quarter worth approximately $27,000. Continuum Advisory LLC raised its position in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the period. Asset Planning Inc bought a new position in Clorox in the fourth quarter worth approximately $32,000. Finally, Catalyst Capital Advisors LLC bought a new position in Clorox in the third quarter worth approximately $54,000. Institutional investors own 78.53% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on CLX. StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and increased their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 price target on shares of Clorox in a research report on Thursday, January 30th. Evercore ISI raised their price objective on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Finally, Barclays raised their price objective on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday, February 5th. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, Clorox presently has an average rating of “Hold” and an average target price of $158.21.

Clorox Stock Performance

CLX opened at $157.41 on Friday. The stock has a market capitalization of $19.39 billion, a price-to-earnings ratio of 43.01, a PEG ratio of 2.58 and a beta of 0.42. The company has a fifty day moving average of $157.87 and a 200 day moving average of $159.63. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the company posted $2.16 earnings per share. As a group, sell-side analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.